/
PPCB
$1.23+$0.01 (+0.82%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$2.8M
2M shares
52-week range
$0.95 – $260.00
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-65999998.77
Propanc Biopharma, Inc. Common Stock
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
www.propanc.com- Employees
- 2
- IPO / List date
- Jun 15, 2012
- HQ
- CAMBERWELL, VICTORIA, C3
Held by traders on TradeandTell
No one on the platform currently holds PPCB.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PPCB as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-18 | 1-for-25reverse |
| 2025-01-29 | 1-for-60000reverse |
| 2023-05-23 | 1-for-1000reverse |
| 2020-11-19 | 1-for-1000reverse |
| 2019-06-24 | 1-for-500reverse |
Recent trades on TradeandTell
No one on the platform has traded PPCB yet.
